Zyflo Cr is a drug owned by Chiesi Usa Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 21, 2013. Details of Zyflo Cr's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6183778 | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
Sep, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Zyflo Cr is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Zyflo Cr's family patents as well as insights into ongoing legal events on those patents.
Zyflo Cr's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Zyflo Cr's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 21, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Zyflo Cr Generic API suppliers:
Zileuton is the generic name for the brand Zyflo Cr. 6 different companies have already filed for the generic of Zyflo Cr, with Aizant having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Zyflo Cr's generic
About Zyflo Cr
Zyflo Cr is a drug owned by Chiesi Usa Inc. Zyflo Cr uses Zileuton as an active ingredient. Zyflo Cr was launched by Chiesi in 2007.
Approval Date:
Zyflo Cr was approved by FDA for market use on 30 May, 2007.
Active Ingredient:
Zyflo Cr uses Zileuton as the active ingredient. Check out other Drugs and Companies using Zileuton ingredient
Dosage:
Zyflo Cr is available in tablet, extended release form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 600MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET, EXTENDED RELEASE | Discontinued | ORAL |